Want to see BODI full AI Analyst Report?
BODI Stock Chart & Stats
$12.22
-$0.55(-8.21%)
At close: 4:00 PM EST
$12.22
-$0.55(-8.21%)
Day’s Range― - ―
52-Week Range$3.75 - $16.87
Previous CloseN/A
Volume12.85K
Average Volume (3M)14.04K
Market Cap
$74.01M
Enterprise Value$48.61M
Total Cash (Recent Filing)$40.84M
Total Debt (Recent Filing)$25.10M
Price to Earnings (P/E)14.0
Beta0.96
Next Earnings
Aug 11, 2026EPS Estimate
-0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.72
Shares Outstanding4,512,761
10 Day Avg. Volume16,626
30 Day Avg. Volume14,040
Financial Highlights & Ratios
PEG Ratio0.26
Price to Book (P/B)2.31
Price to Sales (P/S)0.29
P/FCF Ratio4.16
Enterprise Value/Market Cap0.66
Enterprise Value/Revenue0.21
Enterprise Value/Gross Profit0.29
Enterprise Value/Ebitda1.92
Forecast
1Y Price Target
$18.00Price Target Upside47.30% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)$210.54M
Bulls Say, Bears Say
Bulls Say
High Gross MarginsConsolidated gross margins near ~73% (with digital margins substantially higher) provide durable earnings leverage. High margins allow the company to fund marketing, product and retail expansion while protecting operating profitability even if top-line growth remains soft during the multi-channel transition.
Improved Balance Sheet / Low LeverageMaterial debt reduction and positive equity create financial flexibility and lower refinancing risk. With a de-risked balance sheet management can invest in retail rollouts, product launches and platform improvements without immediate external financing, supporting stability during transformation.
Sustained Adjusted EBITDA And Operating LeverageA long streak of positive adjusted EBITDA coupled with a dramatically lower EBITDA breakeven point shows persistent cost discipline and scalability. This structural improvement enables reinvestment in growth initiatives while maintaining profitability through the omnichannel transition.
Bears Say
Sustained Revenue DeclineA 25% YoY revenue drop in the latest quarter reflects a tangible shrinkage of the core business footprint. Persistent top-line contraction reduces scale economies, limits marketing ROI, and makes it harder to convert margin strength into consistent earnings growth unless subscription or retail initiatives restore demand.
Subscription And Nutrition Demand WeaknessDeclining subscription metrics undermine recurring revenue predictability and customer lifetime value. Weakness across both digital and nutrition cohorts makes the business more reliant on one-off product sales and retail execution, increasing the difficulty of sustaining long-term, repeatable growth.
Cash-Flow Consistency RiskWhile TTM cash generation is positive, FCF declining YoY and converting below reported earnings signals working-capital swings or one-offs. Inconsistent cash conversion can limit the timing and scale of investments in retail distribution and product launches, raising execution risk during the rollout.
Beachbody Company News
BODI FAQ
What was Beachbody Company’s price range in the past 12 months?
Beachbody Company lowest stock price was $3.75 and its highest was $16.87 in the past 12 months.
What is Beachbody Company’s market cap?
Beachbody Company’s market cap is $74.01M.
When is Beachbody Company’s upcoming earnings report date?
Beachbody Company’s upcoming earnings report date is Aug 11, 2026 which is in 41 days.
How were Beachbody Company’s earnings last quarter?
Beachbody Company released its earnings results on May 12, 2026. The company reported $0.327 earnings per share for the quarter, beating the consensus estimate of -$0.082 by $0.409.
Is Beachbody Company overvalued?
According to Wall Street analysts Beachbody Company’s price is currently Undervalued.
Does Beachbody Company pay dividends?
Beachbody Company does not currently pay dividends.
What is Beachbody Company’s EPS estimate?
Beachbody Company’s EPS estimate is -0.21.
How many shares outstanding does Beachbody Company have?
Beachbody Company has 4,512,761 shares outstanding.
What happened to Beachbody Company’s price movement after its last earnings report?
Beachbody Company reported an EPS of $0.327 in its last earnings report, beating expectations of -$0.082. Following the earnings report the stock price went down -2.625%.
Which hedge fund is a major shareholder of Beachbody Company?
Currently, no hedge funds are holding shares in BODI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Beachbody Company Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$18.00 (47.30% Upside)
$18.00 (47.30% Upside)
Blogger Sentiment
Bullish
BODI Sentiment 100%
Sector Average 63%
Sector Average 63%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-22.22%
12-Months-Change
Fundamentals
Return on Equity
18.73%
Trailing 12-Months
Asset Growth
-6.17%
Trailing 12-Months
Company Description
Beachbody Company
The Beachbody Co., Inc. operates as a health and wellness company. It offers holistic health and wellness platforms. The company's product offerings include digital subscriptions, nutritional products, and connected fitness products. Digital subscriptions include Beachbody On Demand (BOD) and Openfit. The subscriptions are renewed on a monthly, quarterly, or annual basis and include unlimited access to a library of live and on-demand fitness and nutrition content. Nutritional products include Shakeology, Beachbody Performance supplements, BEACHBARs, and others. Connected fitness products include The Beachbody Bike (also known as Myx), which is equipped with a swivel touch screen that enables users to engage with content beyond the indoor cycling experience and encourages broader cross-training, incorporating resistance training and yoga for a more holistic fitness experience and healthier results. The company was founded by Carl Daikeler and Jon Congdon in 1998 and is headquartered in El Segundo, CA.
BODI Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call balanced clear evidence of a successful financial turnaround (third consecutive quarters of net income and operating income, 10th consecutive positive adjusted EBITDA, a net cash position, large retail distribution agreements, and product/technology initiatives) against material near-term transition challenges (25% YoY revenue decline, notable subscription declines, nutrition margin pressures, negative free cash flow this quarter and lower sequential adjusted EBITDA). Management emphasized operating leverage, an omnichannel pivot toward nutrition, and concrete retail partnerships that are near-term catalysts, but execution and planogram/timing risks mean the company remains in a transformation phase with both encouraging operational momentum and meaningful short-term headwinds.View all BODI earnings summariesBODI Stock 12 Month Forecast
Average Price Target
$18.00
▲(47.30% Upside)